Kurve Therapeutics, Inc. products

Researchers and scientists have spent the last 25 years trying and failing to develop effective treatments for brain diseases. The majority of the traditional treatments methods available can’t bypass the blood brain barrier, leaving the majority of the medication behind in the nasal cavity, sinuses, or GI tract. Other methods also can produce a number of undesirable side effects. ViaNase™ Intelligent Delivery holds the key to overcoming this frustrating obstacle. This modified approach to treating Central Nervous System disorders uses Kurve Therapeutics’ patented Controlled Particle Dispersion technology to deliver medication precisely where it is needed, providing relief and a sense of wellbeing for patients battling brain disease.

Kurve Therapeutics’ patented Controlled Particle Dispersion (CPD)® technology significantly enhances the efficacy and dosage control of drug formulations by bypassing the blood-brain barrier. Small as well as large, complex molecules have shown promise in treating neurodegenerative diseases, but other non-surgical technology — oral or intravenous — have seen little success in penetrating the blood-brain barrier. We have the answer to distributing medication to this targeted location through our technology’s enhanced reach into the brain.